The mistakes of "Old healthcare reform" lead to bad consequences: the contradiction between the reducing government investment and the rising costs of medical treatment, the contradiction between the nature of the...The mistakes of "Old healthcare reform" lead to bad consequences: the contradiction between the reducing government investment and the rising costs of medical treatment, the contradiction between the nature of the public welfare and the marketization of hospitals, and the contradiction between the unlimited demand growth for medical services and the scarcity of qualified medical resources. The causes of the failure of "old healthcare reform" are the loss of market-oriented reform and the decadence of medical tenet.展开更多
China has been undertaking a profound reform on health care.Although more than 1.16 billion people have been covered by rural and urban medical insurance to date,the level of reimbursement from insurance is very limit...China has been undertaking a profound reform on health care.Although more than 1.16 billion people have been covered by rural and urban medical insurance to date,the level of reimbursement from insurance is very limited,especially for critical diseases such as leukemia.This places heavy economic burdens on patients.Under these circumstances,systems innovation is imperative for the efficient utilization of limited funding.In this respect,certain valuable experience from other countries may prove helpful.The prospective payment system of Diagnosis-related Groups(DRGs),Clinical Paths,and the Comparative Effectiveness Analysis adopted by the National Institute of Health and Clinical Excellence(NICE,UK),can befine tools to reduce medical costs and improve quality of services.Treatments of acute promyelocytic leukemia at Rui-Jin Hospital,and childhood acute lymphoblastic leukemia at Shanghai Children’s Medical Center,can be taken as suitable models to illustrate the crucial role of Clinical Paths in guaranteeing clinical and cost effectiveness of medical services for critical diseases,and to satisfactorily justify the feasibility of DRGs in China.展开更多
To achieve universal health insurance coverage,China has launched three phases of health care system reforms.The first round of reforms was embarked on in the mid-1980s with the introduction of market incentives.The s...To achieve universal health insurance coverage,China has launched three phases of health care system reforms.The first round of reforms was embarked on in the mid-1980s with the introduction of market incentives.The second round began in 1997 with the introduction of the Urban Employee Basic Medical Insurance (UEBMI) scheme which provided health insurance coverage to all urban workers in addition to a long-term/historical scheme for government workers.展开更多
文摘The mistakes of "Old healthcare reform" lead to bad consequences: the contradiction between the reducing government investment and the rising costs of medical treatment, the contradiction between the nature of the public welfare and the marketization of hospitals, and the contradiction between the unlimited demand growth for medical services and the scarcity of qualified medical resources. The causes of the failure of "old healthcare reform" are the loss of market-oriented reform and the decadence of medical tenet.
基金supported in part by the Program of Improving Health Services in China’s Rural Areas supported by the World Bank Loans(Qinghai Province,QHWST-2009KT01).
文摘China has been undertaking a profound reform on health care.Although more than 1.16 billion people have been covered by rural and urban medical insurance to date,the level of reimbursement from insurance is very limited,especially for critical diseases such as leukemia.This places heavy economic burdens on patients.Under these circumstances,systems innovation is imperative for the efficient utilization of limited funding.In this respect,certain valuable experience from other countries may prove helpful.The prospective payment system of Diagnosis-related Groups(DRGs),Clinical Paths,and the Comparative Effectiveness Analysis adopted by the National Institute of Health and Clinical Excellence(NICE,UK),can befine tools to reduce medical costs and improve quality of services.Treatments of acute promyelocytic leukemia at Rui-Jin Hospital,and childhood acute lymphoblastic leukemia at Shanghai Children’s Medical Center,can be taken as suitable models to illustrate the crucial role of Clinical Paths in guaranteeing clinical and cost effectiveness of medical services for critical diseases,and to satisfactorily justify the feasibility of DRGs in China.
基金This work was supported by a grant from NationalNatural Science Foundation of China (No. 71173001).
文摘To achieve universal health insurance coverage,China has launched three phases of health care system reforms.The first round of reforms was embarked on in the mid-1980s with the introduction of market incentives.The second round began in 1997 with the introduction of the Urban Employee Basic Medical Insurance (UEBMI) scheme which provided health insurance coverage to all urban workers in addition to a long-term/historical scheme for government workers.